A phase I single- and multiple-ascending doses trial of AM 125 in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 17 Oct 2018
At a glance
- Drugs Betahistine (Primary) ; Betahistine
- Indications Vertigo
- Focus Adverse reactions; Pharmacokinetics
- 17 Oct 2018 According to an Auris Medical media release, the company will host a conference call and web-cast to review the top-line results from this trial today (October 17, 2018). A live webcast of the conference call can be accessed in the Investor Relations section of the Auris Medical website at www.aurismedical.com.
- 17 Oct 2018 Results presented in the Auris Medical media release.
- 15 Sep 2018 According to an Auris Medical media release, dosing is approaching completion.